Summary & Overview
HCPCS G9220: Pneumocystis jiroveci Pneumonia Prophylaxis Not Prescribed
HCPCS Level II code G9220 documents that Pneumocystis jiroveci pneumonia (PCP) prophylaxis was not prescribed within 3 months after a low CD4+ cell count (<500 cells/mm3) or CD4 percentage (<15%) for a documented medical reason — specifically, because the patient’s CD4+ level rose above threshold within the 3-month window. Nationally, accurate capture of this scenario matters for HIV care quality measurement, care coordination, and claims-based surveillance of prophylaxis use. This code supports clinical documentation when guideline-based prophylaxis is deferred due to improving immune status rather than omission.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical intent and service context, followed by benchmarking and policy-relevant guidance on how G9220 is used in payer adjudication and quality programs. The publication covers coding definitions, potential impacts on quality metrics, common documentation elements expected by payers, and implications for claims reporting and audits. Where specific payer policies and modifiers are not provided in the input, the report notes that data are not available. The focus is national in scope and oriented to clinicians, compliance staff, and billing professionals seeking clear interpretation of G9220 within routine HIV care workflows.
Billing Code Overview
HCPCS Level II code G9220 indicates that Pneumocystis jiroveci pneumonia (PCP) prophylaxis was not prescribed within 3 months after a documented low CD4+ cell count (below 500 cells/mm3) or a CD4 percentage below 15% for a medical reason. The description specifies a clinical scenario in which a patient's CD4+ levels rose above the threshold within 3 months after the low result, such that PCP prophylaxis was deemed not required.
-
Service type: Assessment/documentation of PCP prophylaxis omission for clinical reasons
-
Typical site of service: Outpatient clinic or ambulatory care setting where HIV care and immunologic monitoring occur (e.g., infectious disease clinic, HIV specialty clinic, primary care follow-up)
Data not available in the input for modifiers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A 34-year-old patient with known HIV infection presents for routine follow-up in an infectious disease clinic after a recent laboratory result showed a transient drop in CD4+ T-lymphocyte count to 480 cells/mm3. Three months later, repeat testing demonstrates CD4+ count rising to 520 cells/mm3 and CD4 percentage above 15%. The clinician documents that Pneumocystis jirovecii pneumonia (PCP) prophylaxis was considered but not prescribed within the three-month interval when the CD4+ count was below 500 cells/mm3 for a medical reason because the patient’s CD4+ level recovered above the prophylaxis threshold within three months of the low value. The workflow includes review of historical and current CD4+ lab results, assessment of symptoms and medication tolerability, documentation of the clinical rationale for withholding prophylaxis, and coding the encounter with billing code G9220 to indicate PCP prophylaxis not prescribed within three months of low CD4+ count for a medical reason.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when an E/M visit addressing the decision about PCP prophylaxis is distinct from any other minor procedure performed the same day. |
59 | Distinct procedural service | Use when a separately reportable procedure is performed on the same day and documentation supports distinctness from the counseling/medical decision for PCP prophylaxis.